It is available for people with weight-related health problems with: A BMI of 35 or more, or 32.5 or more for people of Asian, Chinese, Middle Eastern, Black African or African-Caribbean origin
Personalization: From Online Assessment to Genetic Insights A standard online GLP-1 assessment collects baseline dataage, weight, medical history, family history of diabetes, and current medicationsthat help determine medication suitability
( Epub 20200317 )
Orland said the most important takeaway is that the drugs appear to be safe to use for diabetes or weight loss in people undergoing cancer treatment, though its still too soon to recommend GLP-1s for any type of cancer therapy.
Back Molteni, M (17 Oct 2023) 'How one scientist's determination made Novo Nordisk an obesity-drug powerhouse', STAT News